ImmunoPrecise Antibodies Ltd. (IPA)

ImmunoPrecise Antibodies Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 4, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	12	34	64	131	187	38
Market Cap Growth	-65.88%	-47.50%	-50.98%	-30.05%	386.87%	-4.92%
Enterprise Value	21	40	61	107	178	40
Last Close Price	0.43	1.28	2.57	5.56	9.76	2.77
PE Ratio	-	-1.66	-3.27	-8.40	-26.99	-10.62
PS Ratio	0.64	1.89	4.21	8.66	12.87	3.80
PB Ratio	0.49	1.36	1.51	2.23	4.05	3.54
P/FCF Ratio	-4.23	-8.20	-4.08	-15.27	-113.71	-28.80
P/OCF Ratio	-5.39	-10.90	-4.39	-16.91	-384.14	-38.37
EV/Sales Ratio	1.22	2.23	4.02	7.09	12.22	3.96
EV/EBITDA Ratio	-3.48	-5.27	-3.90	-10.58	-47.62	-23.32
EV/EBIT Ratio	-2.74	-3.88	-3.30	-8.20	-32.90	-13.60
EV/FCF Ratio	-5.69	-9.69	-3.90	-12.50	-107.98	-30.06
Debt / Equity Ratio	0.49	0.40	0.13	0.04	0.06	0.30
Debt / FCF Ratio	-2.29	-2.42	-0.34	-0.25	-1.71	-2.43
Asset Turnover	0.35	0.36	0.24	0.24	0.38	0.50
Inventory Turnover	6.12	5.94	4.95	5.95	6.43	7.54
Quick Ratio	0.66	0.98	2.14	3.59	7.56	0.80
Current Ratio	0.99	1.41	2.84	4.03	8.05	0.97
Return on Equity (ROE)	-64.04%	-59.26%	-39.91%	-25.28%	-20.39%	-29.84%
Return on Assets (ROA)	-13.45%	-12.78%	-18.33%	-13.04%	-8.83%	-9.18%
Return on Capital (ROIC)	-16.23%	-15.63%	-21.96%	-15.12%	-10.40%	-12.61%
Earnings Yield	-162.10%	-58.70%	-30.53%	-9.96%	-3.18%	-9.27%
FCF Yield	-40.85%	-12.19%	-24.51%	-6.55%	-0.88%	-3.47%
Buyback Yield / Dilution	-4.73%	-2.97%	-26.46%	-19.51%	-20.88%	-8.67%
Total Shareholder Return	-4.73%	-2.97%	-26.46%	-19.51%	-20.88%	-8.67%

Source: S&P Capital IQ. Standard template. Financial Sources.